Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Abstract of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Chattha, G.
space
  arrow  Tierney, L. M., Jr.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

BRIEF REPORT

Lactic Acidosis Complicating the Acquired Immunodeficiency Syndrome

right arrow Geetinder Chattha, MD; Allen I. Arieff, MD; Cary Cummings, MD; and Lawrence M. Tierney, Jr., MD

1 January 1993 | Volume 118 Issue 1 | Pages 37-39

Lactic acidosis has been reported in patients with the acquired immunodeficiency syndrome (AIDS) only in association with tissue hypoxia. From 1989 to 1991, seven patients with human immunodeficiency virus (HIV) infection who had lactic acidosis without obvious cause were evaluated. Nine normovolemic patients without acidosis or hypoxia served as controls. Findings in the patients included the following: pH, 7.22 ± 0.07; bicarbonate, 7.0 ± 2.4 mmol/L; and lactate, 14.3 ± 2.6 mmol/L. Patients and controls did not differ regarding cardiac index, Po2, oxygen extraction ratio, and systemic oxygen delivery or utilization. Four patients with AIDS died of overwhelming metabolic acidosis, but the three other patients were discharged from the hospital. Autopsy in the four patients who died showed no obvious cause for lactic acidosis. The normal oxygen delivery, utilization, and extraction suggest that increased hyperlactatemia occurred for reasons other than hypoxia. Thus, patients with AIDS but without hypoxia can develop severe lactic acidosis that is not necessarily fatal.


Lactic acidosis, characterized by metabolic acidosis and a blood lactate level higher than 5 mmol/L, is generally classified as either anaerobic (type A) or aerobic (type B) [1]. In type A lactic acidosis, tissue hypoxia and anaerobic metabolism have a definite clinical cause, such as pulmonary edema, cardiopulmonary arrest, or shock. Examples of type B lactic acidosis include that associated with malignancy, glycogen storage diseases, or certain myopathies, where tissue hypoxia is not apparent. In cases where the blood lactate level exceeds about 9 mmol/L, mortality may exceed 75% [2]. Patients with human immunodeficiency virus (HIV) infection may develop type A lactic acidosis associated with tissue hypoxia related to sepsis, shock, or cardiac arrest [3]. During a 2-year period, however, we encountered seven HIV-infected patients who developed severe lactic acidosis in the absence of hypoxemia or another obvious cause.


Methods
space
up arrowTop
dotMethods
down arrowResults
down arrowDiscussion
down arrowAuthor & Article Info
down arrowReferences

Between July 1989 and June 1991, seven patients with confirmed HIV infection (six with AIDS; one with AIDS-related complex) [4] developed lactic acidosis. The patients presented with the following symptom complexes: nausea, emesis, and anorexia with weight loss (n = 4); fever and malaise (n = 2); and tachypnea with dyspnea (n = 3) (Table 1). Metabolic acidosis was diagnosed in three patients at admission to the hospital because of dyspnea, whereas dyspnea or a decrease in the blood bicarbonate level led to evaluation of arterial blood gases in four other patients (Table 1). The control group included nine age-matched patients admitted to the same intensive care unit over the same interval who had placement of a pulmonary artery catheter [5] for close monitoring of volume status. When studied, all controls were normovolemic (normal cardiac output and pulmonary artery pressure), and none had metabolic acidosis, hypoxia, or clinical evidence of a mixed acid-base disorder. The cardiac output was determined by thermodilution [5]; the blood lactate level, oxygen delivery, and oxygen utilization were assessed as previously reported [6, 7]. Data are expressed as mean ±SD. The unpaired Student t-test was used for comparisons.


View this table:
[in this window]
[in a new window]
 
Table 1. Seven Patients with Human Immunodeficiency Virus Infection and Lactic Acidosis*

 


Results
space
up arrowTop
up arrowMethods
dotResults
down arrowDiscussion
down arrowAuthor & Article Info
down arrowReferences

When lactic acidosis was diagnosed, six of the seven patients were lucid and generally had no symptoms except hyperventilation (see Table 1). Other causes for elevated anion gap metabolic acidosis, such as diabetic ketoacidosis, malignancy, sepsis, uremia, thyrotoxicosis, or exogenous intoxication were ruled out by appropriate laboratory tests and diagnostic procedures and by autopsy in four cases. No single drug was being taken by all seven patients: Four patients were receiving zidovudine, one patient was receiving ganciclovir, and one patient was receiving clofazimine. Values at the time of diagnosis of lactic acidosis (see Table 1) were as follows: arterial oxygen saturation, 98% ± 1%; arterial lactate, 14.3 ± 2.6 mmol/L (controls, 1.6 ± 0.8 mmol/L; P < 0.001); and anion gap, 28 ± 5 mmol/L (controls, 11 ± 2 mmol/L; P < 0.001). The oxygen extraction ratio {100 x (arterial O2 – venous O2)/arterial O2} (O2 expressed as mL O2/100 mL blood) was 24.9% ± 6.0%, which did not differ from that of controls (19.5% ± 7.8%; P = 0.2).

In three patients, the cardiac index was 3.20 ± 0.21 L/min per m (2) body surface area (control value 3.19 ± 1.38 L/min per m2; P > 0.2) when the blood lactate level was 14.2 mmol/L. The systemic oxygen delivery was 938 ± 118 mL/min (controls, 1137 ± 490 mL/min; P > 0.2) and oxygen utilization was 211 ± 51 mL/min (controls, 213 ± 87 mL/min; P > 0.2). Thus, cardiac output, oxygen extraction, and both oxygen delivery and utilization were in the normal range [7, 8] and did not differ in controls (Figure 1).



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. Oxygen delivery, oxygen utilization, and cardiac index in three patients with the acquired immunodeficiency syndrome (AIDS) and lactic acidosis and in nine control patients. The cardiac index and oxygen delivery and utilization are all within one standard deviation (SD) of the control values. Data are presented as mean ±SD.

 

Four patients died of cardiovascular collapse secondary to progressive metabolic acidosis (see Table 1). In all four, the arterial pH fell below 6.85 and the lactate level was higher than 15 mmol/L before death. However, in the other three patients, arterial pH and blood levels of lactate did not change substantially during hospitalization, and all were discharged in a lucid and ambulatory state. Within 15 months, all had died of other complications of AIDS (see Table 1).


Discussion
space
up arrowTop
up arrowMethods
up arrowResults
dotDiscussion
down arrowAuthor & Article Info
down arrowReferences

In seven patients with HIV infection who did not have shock, sepsis, malignancy, or other causes of systemic hypoxemia, lactic acidosis developed suddenly and without obvious cause. In these patients, the arterial Po2, cardiac index, oxygen delivery, oxygen utilization, and oxygen extraction ratio were not significantly different from those of controls, providing no evidence for systemic hypoxemia or tissue hypoxia. Although oxygen delivery and utilization were evaluated in only three patients, the normal oxygen extraction ratio strongly suggests that all had normal oxygen utilization. All had normal blood pressure with no evidence of shock or sepsis, so that substantial shunting of blood was clinically unlikely.

The disorder in the patients resembled adult Reye syndrome, in that type B lactic acidosis was associated with a probable infectious cause [9]. Increased production of lactate may also have been associated with a myopathy related to zidovudine therapy. Such a myopathy can cause a decrease of muscle respiratory chain capacity in some patients with AIDS [10]. Lactic acidosis was a major comorbid event in four patients, but the other three survived an average of 32 weeks, suggesting a heterogeneous cause.

This study was presented in part at the 23rd Annual Meeting, American Society of Nephrology, November 1991, Baltimore, Maryland.


Author and Article Information
space
up arrowTop
up arrowMethods
up arrowResults
up arrowDiscussion
dotAuthor & Article Info
down arrowReferences

From the Veterans Affairs Medical Center and the University of California School of Medicine, San Francisco, California.
Requests for Reprints: Allen I. Arieff, MD, Department of Medicine (111 G), Veterans Affairs Medical Center, 4150 Clement Street, San Francisco, California 94121.
Acknowledgments: The authors thank Drs. T. G. Patel, D. J. Connito, and P. Pointier of the Nephrology Service, Naval Hospital, Portsmouth, Virginia, and Dr. H. Boroujerdi, Department of Medicine, St. Raphael Hospital, Oakville, Connecticut, for permission to report data on patients under their care.
Grant Support: In part by the Research Service of the Veterans Affairs Medical Center, San Francisco, California. Dr. C. Cummings is a Fellow of the National Kidney Foundation.


References
space
up arrowTop
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowAuthor & Article Info
dotReferences

1. Cohen RD. The metabolic background to acid-base homeostasis and some of its disorders: lactic acidosis. In: Cohen RD, Lewis B, Alberti KG, Denman AM, eds. The Metabolic and Molecular Basis of Acquired Disease. Philadelphia: W.B. Saunders; 1990:981-8.

2. Peretz DL, Scott HM, Duff J. The significance of lactic acidemia in the shock syndrome. Ann NY Acad Sci. 1965; 119:1133-41.

3. Madias NE. Lactic acidosis. Kidney Int. 1986; 29:752-74.

4. Andrulis DP, Weslowski VB, Hintz E, Spolarich AW. Comparisons of hospital care for patients with AIDS and other HIV-related conditions. JAMA. 1992; 267:2482-6.

5. Ganz W, Donose R, Marcus HS, Forrester JS, Swan HJ. A new technique for measurement of cardiac output by thermodilution in man. Am J Cardiol. 1971; 27:392-6.

6. Arieff AI, Graf H. Pathophysiology of type A hypoxic lactic acidosis in dogs. Am J Physiol. 1987; 253:E271-6.

7. Bersin RM, Chatterjee K, Arieff AI. Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med. 1989; 87:7-14.

8. Gutierrez G, Bismar H, Dantzker DR, Silva N. Comparison of gastric intramucosal pH with measures of oxygen transport and consumption in critically ill patients. Crit Care Med. 1992; 20:451-7.

9. Aiyathurai JE, Wong HB, Quak SH, Jacob E, Chio LF, Sothy SP. The significance of type B hyperlactataemia in infective encephalopathy. Ann Acad Med Singapore. 1983; 12:115-25.

10. Mhiri C, Baudrimont M, Bonne G, Geny C, Degoul F, Marsac C, et al. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction. Ann Neurol. 1991; 29:606-14.


This article has been cited by other articles:


Home page
CJASNHome page
J. S. Berns and N. Kasbekar
Highly Active Antiretroviral Therapy and the Kidney: An Update on Antiretroviral Medications for Nephrologists
Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 117 - 129.
[Abstract] [Full Text] [PDF]


Home page
J Intensive Care MedHome page
P. J. Fall and H. M. Szerlip
Lactic Acidosis: From Sour Milk to Septic Shock
J Intensive Care Med, September 1, 2005; 20(5): 255 - 271.
[Abstract] [PDF]


Home page
J Antimicrob ChemotherHome page
C. L. Cherry and S. L. Wesselingh
Nucleoside analogues and HIV: the combined cost to mitochondria
J. Antimicrob. Chemother., May 1, 2003; 51(5): 1091 - 1093.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Lewis
Defective mitochondrial DNA replication and NRTIs: pathophysiological implications in AIDS cardiomyopathy
Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H1 - H9.
[Full Text] [PDF]


Home page
ImagingHome page
N P Smith and A L Pozniak
The changing face of HIV
Imaging, February 1, 2002; 14(1): 1 - 7.
[Abstract] [Full Text] [PDF]


Home page
Sex. Transm. Infect.Home page
D Pao, C Watson, B Peters, S B Lucas, and R F Miller
Hyperlactataemia and hepatic steatosis: mitochondrial toxicity of nucleoside reverse transcriptase inhibitors
Sex. Transm. Inf., October 1, 2001; 77(5): 381 - 384.
[Full Text] [PDF]


Home page
AIDS Clin CareHome page
NRTI-Associated Mitochondrial Toxicity
AIDS Clinical Care, May 1, 2001; 2001(501): 7 - 7.
[Full Text]


Home page
ANN INTERN MEDHome page
K. D. Miller, M. Cameron, L. V. Wood, M. C. Dalakas, and J. A. Kovacs
Lactic Acidosis and Hepatic Steatosis Associated with Use of Stavudine: Report of Four Cases
Ann Intern Med, August 1, 2000; 133(3): 192 - 196.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
R. Chodock, E. Mylonakis, D. Shemin, V. Runarsdottir, P. Yodice, R. Renzi, K. Tashima, C. Towe, and J. D. Rich
Survival of a human immunodeficiency patient with nucleoside-induced lactic acidosis—role of haemodialysis treatment
Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2484 - 2486.
[Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
B. Allaouchiche, F. Duflo, L. Cotte, L. Mathon, and D. Chassard
Acute pancreatitis with severe lactic acidosis in an HIV-infected patient on didanosine therapy
J. Antimicrob. Chemother., July 1, 1999; 44(1): 137 - 138.
[Full Text] [PDF]


Home page
NEJMHome page
R. McKenzie, M. W. Fried, R. Sallie, H. Conjeevaram, A. M. Di Bisceglie, Y. Park, B. Savarese, D. Kleiner, M. Tsokos, C. Luciano, et al.
Hepatic Failure and Lactic Acidosis Due to Fialuridine (FIAU), an Investigational Nucleoside Analogue for Chronic Hepatitis B
N. Engl. J. Med., October 26, 1995; 333(17): 1099 - 1105.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W. M. Lee
Drug-Induced Hepatotoxicity
N. Engl. J. Med., October 26, 1995; 333(17): 1118 - 1127.
[Full Text] [PDF]


box Article
 arrow  Table of Contents                
space
 arrow  Abstract of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Chattha, G.
space
  arrow  Tierney, L. M., Jr.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online